Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2018
Agenda for the November 2018 PBAC meeting
22 August 2018 - The agenda for the November 2018 PBAC meeting is now available. ...
Posted by Michael Wonder on 22 Aug 2018
PBAC Drug Utilisation Sub-Committee utilisation analysis - public release documents
22 August 2018 - The utilisation analysis public release documents from the February 2018 DUSC meeting are now available. ...
Posted by Michael Wonder on 21 Aug 2018
NHS Scotland works up 'detailed' no-deal Brexit plan
21 August 2018 - Scotland's NHS has drawn up "detailed plans" to ensure enough medicine and equipment in the event ...
Posted by Michael Wonder on 21 Aug 2018
No-deal Brexit could see hospitals run out of medicine, reveals leaked letter from health chief
21 August 2018 - Ministers and health service bosses have failed to prepare for UK crashing out of European Union, say ...
Posted by Michael Wonder on 21 Aug 2018
NHS managers warn no-deal Brexit risks drug shortages
21 August 2018 - NHS trusts are warning that the health service is not prepared for a no-deal Brexit and ...
Posted by Michael Wonder on 21 Aug 2018
Proposal to change the funded brand of epoetin alfa
21 August 2018 - PHARMAC is seeking feedback on a proposed change to the funded brand of epoetin alfa [erythropoietin ...
Posted by Michael Wonder on 20 Aug 2018
Treatment funded in Australia, but New Zealand brother misses out
21 August 2018 - James McGoram says the genetic disease he has is yet to affect his day-to-day life but ...
Posted by Michael Wonder on 20 Aug 2018
PBAC recommendation moves approximately 1,300 patients in Australia closer to access to lumacaftor/ivacaftor and Vertex is now working with the Australian Government to finalize a reimbursement agreement as soon as possible
20 August 2018 - Vertex Pharmaceuticals announces that it has received the PBAC recommendation for Orkambi (lumacaftor/ivacaftor) to be listed on ...
Posted by Michael Wonder on 20 Aug 2018
Proposal to list nintedanib (Ofev) and remove restrictions from tiotropium bromide (Spiriva)
20 August 2018 - PHARMAC is seeking feedback on a proposal to list nintedanib (Ofev) and remove the current funding ...
Posted by Michael Wonder on 20 Aug 2018
Network meta-analysis in health care decision-making
20 August 2018 - Systematic reviews and meta-analyses play a crucial role in clinical decision making. ...
Posted by Michael Wonder on 19 Aug 2018
Insights from the July 2018 PBAC meeting
20 August 2018 - Highest recommendation rate for a scheduled PBAC meeting in modern times. ...
Posted by Michael Wonder on 18 Aug 2018
Life saving cancer drug Keytruda worth $150,000 goes on the PBS
19 August 2018 - Melbourne academic and lung cancer patient John Burke has spent $80,000 on the drug that saved ...
Posted by Michael Wonder on 18 Aug 2018
Pharmaceutical Benefits Advisory Committee recommends Orkambi for PBS
17 August 2018 - Cystic fibrosis sufferers across Australia will now have access to a life-changing drug after the Federal ...
Posted by Michael Wonder on 17 Aug 2018
Hundreds of cancer patients received partial doses of medication
16 August 2018 - Hundreds of cancer patients in Canada did not receive the full dose of three highly concentrated ...
Posted by Michael Wonder on 17 Aug 2018
Recommendations made by the PBAC - July 2018
17 August 2018 - The recommendations from the July 2018 PBAC meeting are now available. ...